McDermott Will & Schulte, a global law firm

A recent McDermott round table on European health private equity generated key insights into the future of medtech, digital health, and data analytics, and identified opportunities for companies and investors. Read More.

Generally, an outbound investment by a Chinese enterprise must be approved by the competent national authorities or their local bodies before it can be closed. Read More.

Despite trade wars and economic shifts in China and the European Union, early-stage investing in life sciences, particularly in the biotechnology and medical device sectors, remains strong and presents myriad opportunities for the prepared. Read More.

The US Treasury Department has issued proposed regulations that would “comprehensively” implement FIRRMA, to broaden the jurisdiction of CFIUS. Read More.

Governments are starting to catch up with online businesses. Multinational businesses providing online advertising services, selling consumer data, or running online intermediary platforms, should prepare for the imminent arrival of digital services taxes (DSTs) on revenues from digital activities. Read More.

The UK Competition and Markets Authority (CMA) is actively and aggressively investigating mergers and acquisitions pre- and post-closing, including transactions that do not appear to have a significant UK connection. Read More.

On 1 March 2019, the Milan Chamber of Arbitration (CAM), the leading Italian arbitration institution, issued its revised Arbitration rules. These are intended to provide for a more efficient administration of arbitral proceedings. Read More.

All electrical and electronic products that are produced, sold or imported in mainland China must comply with the Administrative Measures on the Restricted Use of Hazardous Substances in Electrical and Electronic Products (China RoHS 2.0). Read More.